News

pharmaphorum
pharmaphorum. com > oncology > asco-2026-can-blood-test-spot-cancer-early-dr-peter-sasieni

ASCO 2026: Can a blood test spot cancer early? with Dr Peter Sasieni

22+ hour, 2+ min ago  (350+ words) The NHS Galleri Trial, a massive undertaking hoping to improve cancer outcomes through early detection, may not have met its primary outcome measure. But it did demonstrate a lot about what's possible using blood screening for early cancer detection at…...

Symbols: asx:bdx,nasdaq:aidx
pharmaphorum
pharmaphorum. com > oncology > car-t-has-geography-problem

CAR-T has a geography problem

1+ day, 3+ hour ago  (559+ words) When Sam Neill announced he had received CAR-T cell therapy and was in remission, the coverage was celebratory and rightly so. A beloved actor. A remarkable outcome. A story about what modern medicine can do. But buried in that story…...

Symbols: d05.S0,u11.S0,z74.S0,1h3.S0,5dx.si,awg.si
pharmaphorum
pharmaphorum. com > rd > women-stem-overcoming-exclusionary-workplace-culture

Women in STEM: Overcoming exclusionary workplace culture

1+ day, 2+ hour ago  (484+ words) As of 2026, women remain underrepresented in STEM fields, but initiatives like the Women and Underrepresented Minorities in STEM Booster Act aim to enhance diversity and support for women in these areas. In order to continue to review how far gender…...

pharmaphorum
pharmaphorum. com > digital > how-norwegian-hospital-unlocked-capacity-without-adding-staff

How a Norwegian hospital unlocked capacity without adding staff

1+ day, 4+ hour ago  (825+ words) Within that complexity, bottlenecks emerge, a single constraint that quietly limits everything else. Managing something this complex, with interdependent moving parts and shifting bottlenecks, is beyond what traditional planning tools were built for. At Lovisenberg Diaconal Hospital in Norway, however,…...

pharmaphorum
pharmaphorum. com > news > moderna-shows-vivo-car-t-hand-rd-update

Moderna shows in vivo CAR-T hand in R&D update

1+ day, 6+ hour ago  (561+ words) At its latest R&D update, Moderna revealed a move into the pioneering in vivo CAR-T category, adding another treatment class to its R&D capabilities. It has nominated a lead candidate in the in vivo CAR-T programme, codenamed m…...

Symbols: nasdaq:allo,nasdaq:anix
pharmaphorum
pharmaphorum. com > news > sanofi-faces-eu-investigation-over-flu-shot-marketing

Sanofi faces EU investigation over flu shot marketing

1+ day, 5+ hour ago  (589+ words) The European Commission has opened an investigation into a marketing campaign run by Sanofi for an influenza vaccine, and whether it disparaged its only rival in the market. Specifically, it is looking into promotional activities for Sanofi's enhanced flu vaccine…...

Symbols: san-fr,euronext:san,nasdaq:sny,btc-usd,nasdaq:mrna
pharmaphorum
pharmaphorum. com > news > obesity-rising-fastest-young-adults-england

Obesity is rising fastest in young adults in England

1+ day, 8+ hour ago  (706+ words) Around a third of adults in England are now living with obesity, and new cases are rising most quickly in younger adults, according to an analysis of electronic health records (EHRs) for more than 54 million people. Researchers used EHRs from…...

Symbols: nfhs-6
pharmaphorum
pharmaphorum. com > digital > integration-key-scalable-decentralised-trials

Integration: The key to scalable decentralised trials

2+ day, 2+ hour ago  (358+ words) pharmaphorum Some of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness. - pharmaphorum. com 1 __eoi Used in order to detect spam and improve the website's security. Maximum Storage Duration: 180 days Type: HTTP Cookie - Preferences…...

Symbols: btc-usd
pharmaphorum
pharmaphorum. com > news > hub-and-spoke-firm-osanni-raises-190m-and-other-financings

Hub-and-spoke firm Osanni raises $190m, and other financings

2+ day, 33+ min ago  (662+ words) Our latest roundup of venture capital financings in the biotech sector includes rounds for Osanni Bio, Bionyra, Serapha, Nura Bio, and Oblenio. San Francisco-based development-stage therapeutics company, Osanni Bio, has been thrust into the spotlight this week with an impressive…...

Symbols: nasdaq:osis
pharmaphorum
pharmaphorum. com > news > merck-buys-life-sciences-firm-bio-techne-113bn-deal

Merck buys life sciences firm Bio-techne in $11. 3bn deal

1+ day, 23+ hour ago  (549+ words) Germany's Merck KGa A is poised to increase the size of its life sciences business, which provides tools for research, drug discovery, and manufacturing, with an $11. 3 billion deal to acquire US rival Bio-techne. Merck is paying $73 billion in cash for…...

Symbols: nyse:mrk